NDT Effectiveness Study

Cerebral Palsy Clinical Trial

Official title:

Determining the Efficacy of the Neurodevelopmental Treatment Contemporary Practice Model for the Treatment of Children With Cerebral Palsy or Other Neuromuscular Conditions to Improve Functional Outcomes.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05070910
• Other study ID #: 2021/04/10
• Status: Completed
• Phase: N/A
• Start date: October 25, 2021
• Est. completion date: March 31, 2022

Study information

• Verified date: January 2023
• Source: MultiCare Health System Research Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether there is a functional change in children with Cerebral Palsy (CP) and other neuromuscular disorders participating in Neurodevelopmental Treatment (NDT) intervention using the contemporary practice model (CPM).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Est. completion date: March 31, 2022
• Est. primary completion date: March 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 2 Years to 15 Years

Eligibility

Inclusion Criteria:

• The children will be aged 2 to 15 years with a diagnosis of CP, hypotonia, global developmental delay and/ or neuromuscular disorders not otherwise specified.

• Children must also be willing to receive physical guidance for movement and clearly attempt to respond to simple instructions on request.

• Children and their families are available and willing to attend the practicum portion of the course for both blocks.

Exclusion Criteria:

• Parent/Guardian unable to complete the 4 required interview sessions.

• Unable to commit to attending 75% of practicum sessions.

Related Conditions & MeSH terms

• Cerebral Palsy
• Neuromuscular Diseases

Intervention

Behavioral:
• Therapy
The intervention performed in the practicum will not be able to be influenced by the study investigators and the intervention may be different for each child based on their needs

Locations

Country	Name	City	State
United States	Good Samaritan Hospital	Puyallup	Washington

Sponsors (1)

Lead Sponsor	Collaborator
MultiCare Health System Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Significant increase in functional outcomes in COPM scores	Change functional outcomes in COPM scores after NDT-CPM treatment.	Significant change after an 8 week NDT-CPM treatment occurring from November 2, 2021 to completion on March 12, 2022